Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...

Pfizer faces weak growth, sector headwinds, and pipeline uncertainty despite cost cuts and a 7% yield, weighing on sentiment.

In the most recent trading session, Pfizer (PFE) closed at $23.27, indicating a -2.29% shift from the previous trading day.

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Shares of Pfizer Inc. PFE slid 2.18% to $23.29 Thursday, on what proved to be an all-around dismal trading session for the ...

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

Pfizer Inc ( (PFE) ), Astellas Pharma ( (ALPMF) ), Astellas Pharma ( (ALPMY)) announced an update on their ongoing clinical study.

AbbVie (ABBV) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.89 per share. This compares to earnings of $2.65 per share a year ago. These figures are ...

Trump said his move is aimed at stopping "global freeloading" and guarantee that Americans pay the same drug prices enjoyed ...

Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the United States, months after signing a sweeping ...

Pharmaceutical CEOs are on notice about sky-high drug prices as President Donald Trump demands a recalibration of what Americans are paying compared to other countries.